Director Seah Lim resigns from Emmaus Life Sciences board for personal reasons

Emmaus Life Sciences, Inc.

Dr. Seah Lim resigned as director on November 4, 2024, citing personal reasons.
No replacement or successor director has been named at this time.
The company expressed gratitude for Dr. Lim's service and support.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Seah Lim

director

EMMA · Emmaus Life Sciences, Inc.

Effective: 2024-11-04
Filed: November 6, 2024, 6:59 PM ET

On November 4, 2024, Seah Lim, M.D., Ph.D., resigned as a director of Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” or the “company”) for personal reasons and expressed his best wishes to the company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Seah Lim resigned as director at Emmaus Life Sciences, Inc..

Action: resigned
Role: director

Exact text from the filing

On November 4, 2024, Seah Lim, M.D., Ph.D., resigned as a director of Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” or the “company”) for personal reasons and expressed his best wishes to the company.

View on SEC.gov

Emmaus Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-094976

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.